Bioxyne Limited (ASX:BXN)
Australia
· Delayed Price · Currency is AUD 0.0580
+0.0040 (7.41%)
Mar 10, 2026, 1:53 PM AEST
Bioxyne Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | 8.97 | 4.9 | -13.33 | -1.94 | -0.49 | -0.5 | Upgrade
|
| Depreciation & Amortization | 0.9 | 0.66 | 0.23 | 0.11 | 0.03 | 0.07 | Upgrade
|
| Other Amortization | 0.1 | 0.1 | 0.03 | - | - | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.08 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 11.57 | 0.09 | 0.04 | - | Upgrade
|
| Stock-Based Compensation | 1.21 | 1.21 | 0.14 | 0.7 | 0.1 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 0.01 | - | Upgrade
|
| Other Operating Activities | -8.82 | -0.26 | 0.04 | -0.38 | -0.07 | 0.03 | Upgrade
|
| Change in Accounts Receivable | -2.05 | -2.05 | -1.22 | -0.6 | -0.27 | 0.02 | Upgrade
|
| Change in Inventory | -1.46 | -1.46 | -1.15 | -0.92 | -0.08 | 0.4 | Upgrade
|
| Change in Accounts Payable | 3.18 | 3.18 | 0.04 | 1.81 | 0.21 | 0.02 | Upgrade
|
| Operating Cash Flow | 2.02 | 6.28 | -3.56 | -1.13 | -0.51 | 0.05 | Upgrade
|
| Operating Cash Flow Growth | 25.87% | - | - | - | - | 10.13% | Upgrade
|
| Capital Expenditures | -1.74 | -2.07 | -0.18 | -0.06 | -0.06 | - | Upgrade
|
| Cash Acquisitions | - | - | - | 4.16 | 0.09 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.31 | - | - | - | Upgrade
|
| Investing Cash Flow | -1.74 | -2.07 | -0.49 | 4.1 | 0.03 | - | Upgrade
|
| Long-Term Debt Issued | - | 0.39 | - | 0.22 | 0.49 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.43 | -0.14 | - | - | -0.05 | Upgrade
|
| Net Debt Issued (Repaid) | 2.1 | -0.04 | -0.14 | 0.22 | 0.49 | -0.05 | Upgrade
|
| Issuance of Common Stock | 2.56 | 2.45 | 1.35 | 0.58 | - | - | Upgrade
|
| Financing Cash Flow | 4.66 | 2.42 | 1.21 | 0.81 | 0.49 | -0.05 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.02 | 0.02 | 0.02 | 0 | -0.01 | -0.15 | Upgrade
|
| Net Cash Flow | 4.92 | 6.64 | -2.82 | 3.78 | 0 | -0.15 | Upgrade
|
| Free Cash Flow | 0.28 | 4.21 | -3.74 | -1.19 | -0.57 | 0.05 | Upgrade
|
| Free Cash Flow Growth | 99.27% | - | - | - | - | 264.26% | Upgrade
|
| Free Cash Flow Margin | 0.59% | 14.37% | -38.77% | -22.45% | -122.27% | 2.41% | Upgrade
|
| Free Cash Flow Per Share | - | 0.00 | -0.00 | -0.00 | -0.00 | - | Upgrade
|
| Cash Interest Paid | 0.17 | 0.13 | - | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | -0.07 | - | - | Upgrade
|
| Levered Free Cash Flow | -2.3 | 2.83 | -2.61 | -0.54 | 0.03 | 0.33 | Upgrade
|
| Unlevered Free Cash Flow | -2.27 | 2.83 | -2.61 | -0.54 | 0.03 | 0.33 | Upgrade
|
| Change in Working Capital | -0.33 | -0.33 | -2.33 | 0.29 | -0.13 | 0.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.